Health Assurance Acquisition Corp. (NASDAQ: HAAC) announced in a press release this afternoon that due to its inability to complete a business combination, it will dissolve and liquidate its trust.
The SPAC originally had a completion deadline of November 17, but now expects its shares to stop trading on the Nasdaq as of the close of business on November 3. HAAC’s Class A ordinary shares will be deemed cancelled and will represent only the right to receive the redemption amount of $10.05 on or around November 18. The balance of the trust as of September 30, was $527,908,312, which includes $2,908,312 in interest and dividend income, excess of cash over $525 million the funds deposited into the account.
In accordance with the terms of the trust agreement, HAAC expects to retain $100,000 of the interest and dividend income from the trust to pay dissolution expenses.
The SPAC announced the pricing of its $500 million IPO in November of 2020 and intended to combine with a tech-enabled healthcare target. HAAC now marks the 44th SPAC to announce a liquidation this year.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...